METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS

FGF21 Mutants and Uses Thereof

Antigenic Epstein Barr Virus Polypeptides

METHODS FOR GENERATING PRIMARY IMMUNE CELLS

ANTI-CD25 ANTIBODY AGENTS

ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION

Antigenic epstein barr virus polypeptides

Self-assembled nanoparticle containing gB protein of EB virus and preparation method and use thereof

POLYPEPTIDE ENCODED BY EB VIRUS BNLF2B GENE AND USE THEREOF IN DETECTION

Antigenic Epstein Barr virus polypeptides

Expression system for expressing herpesvirus glycoprotein complexes

EBV-SPECIFIC IMMUNE CELLS

Viral Origin of Replication to Increase Protein Productivity from Mammalian Cells

EPSTEIN-BARR VIRUS NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME

Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e

Ii vaccine adjuvant

Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection

Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

INDUCED IMMUNOLOGICAL RESPONSE TO CANCEROUS CELLS USING VECTORS CONTAINING VIRAL GENES

Anti-CD25 for tumour specific cell depletion

Anti-CD25 for tumour specific cell depletion

Epstein-Barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same

Antigenic Epstein Barr virus polypeptides

Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

Expression system for expressing herpesvirus glycoprotein complexes

Ii vaccine adjuvant

METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS

Re-directed immunotherapy

Recombinant respiratory syncytial virus G protein fragments

Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Cell penetrating peptides

Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

Use of peptides as transporters intended for the internalization of molecules of interest into target cells

Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling

Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells

GB virus C (hepatitis G virus) for the treatment of HIV

EBV-specific immune cells